Phase 0 clinical trials

Last revised by Henry Knipe on 17 Apr 2015

Phase 0 clinical trials are the first step in evaluating a possible new drug on humans, and are designed to evaluate the  pharmacodynamics and pharmacokinetics of the drug in humans. They are typically performed on a small number of subjects (e.g. a dozen or so) who are administered subtherapeutic doses 1

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.